Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
posted on
Sep 16, 2019 02:21PM
BETonMACE committees, as listed in the appendix of the BETonMACE trial design paper:
Executive Steering Committee: Kausik K. Ray MD MPhil, (Chair); Henry Ginsberg MD, Kamyar Kalantar-Zadeh MD PhD, Stephen J. Nicholls MD PhD, Gregory G. Schwartz MD PhD, Peter P. Toth MD PhD. Sponsor representatives: Michael Sweeney MD, Jan O. Johansson MD PhD, Ewelina Kulikowski PhD, Norman Wong MD
National Leaders: Argentina, Marisa Vico MD and Alberto Lorenzatti, MD; Mexico, Edmundo Bayram Llamas MD; Bulgaria, Maria Milanova MD; Croatia, Zeljko Popovic MD; Germany, Henning Ebelt MD; Hungary, Róbert Kiss MD PhD; Israel, Basil Lewis MD; Poland, Maciej Banach MD PhD; Serbia, Milan Pavlovic MD; Slovak Republic, Daniel Pella MD PhD; Taiwan, Chern-En Chiang MD PhD
Data Safety Monitoring Board: Eva Lonn, MD, (Chair); Lawrence Alan Leiter, MD; David Waters, MD; Michael Szarek, PhD; Paul Watkins, MD; Judith Currier, MD
Clinical Events Committee: John J.V. McMurray MD (Chair); Mark Petrie MD; Eugene Conolly MD; Pradeep Jhund MD; Ninian, Lang MD; Matthew Walters MD